West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 95,600 | 62,200 | 60,700 | 32,900 | 127,100 |
| Depreciation Amortization | 89,900 | 66,600 | 44,200 | 22,000 | 90,000 |
| Income taxes - deferred | -8,900 | N/A | N/A | N/A | 7,000 |
| Accounts receivable | -14,100 | N/A | N/A | N/A | -6,300 |
| Accounts payable and accrued liabilities | 17,200 | N/A | N/A | N/A | -3,500 |
| Other Working Capital | -10,800 | -55,100 | -48,500 | -61,100 | -30,600 |
| Other Operating Activity | 43,500 | 70,700 | 19,200 | 4,300 | -800 |
| Operating Cash Flow | $212,400 | $144,400 | $75,600 | $-1,900 | $182,900 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | 7,500 |
| PPE Investments | -131,600 | -86,800 | -57,100 | -30,400 | -111,900 |
| Purchase Of Investment | -1,500 | N/A | N/A | N/A | -500 |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -200 |
| Other Investing Activity | 3,600 | 1,200 | 1,000 | -200 | 900 |
| Investing Cash Flow | $-129,500 | $-85,600 | $-56,100 | $-30,600 | $-104,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 57,400 | N/A | N/A | 263,400 |
| Debt Repayment | 44,000 | -84,100 | 42,400 | 5,700 | -285,700 |
| Common Stock Issued | 15,900 | 12,000 | 9,700 | 7,300 | 17,100 |
| Common Stock Repurchased | -5,600 | -5,600 | -5,600 | -5,700 | -4,100 |
| Dividend Paid | -32,400 | -23,700 | -15,800 | -7,900 | -29,100 |
| Other Financing Activity | -63,400 | 4,100 | -40,200 | 1,800 | 7,600 |
| Financing Cash Flow | $-41,500 | $-39,900 | $-9,500 | $1,200 | $-30,800 |
| Exchange Rate Effect | -22,100 | -17,400 | -13,300 | -16,900 | -22,800 |
| Beginning Cash Position | 255,300 | 255,300 | 255,300 | 255,300 | 230,000 |
| End Cash Position | 274,600 | 256,800 | 252,000 | 207,100 | 255,300 |
| Net Cash Flow | $19,300 | $1,500 | $-3,300 | $-48,200 | $25,300 |
| Free Cash Flow | |||||
| Operating Cash Flow | 212,400 | 144,400 | 75,600 | -1,900 | 182,900 |
| Capital Expenditure | -131,600 | -86,800 | -57,100 | -30,400 | -111,900 |
| Free Cash Flow | 80,800 | 57,600 | 18,500 | -32,300 | 71,000 |